Hanman Fit Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 18, 2025, 12:23 am

Competitors of Hanman Fit Ltd

All Competitor Stocks of Hanman Fit Ltd

Quarterly Result

Last Updated: August 19, 2025, 5:30 pm

Below is a detailed analysis of the quarterly data for Hanman Fit Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Sep 2024) to 0.03 Cr., marking an increase of 0.03 Cr..
• For Expenses, as of Mar 2025, the value is 0.27 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.46 Cr. (Sep 2024) to 0.27 Cr., marking a decrease of 0.19 Cr..
• For Operating Profit, as of Mar 2025, the value is -0.24 Cr.. The value appears strong and on an upward trend. It has increased from -0.46 Cr. (Sep 2024) to -0.24 Cr., marking an increase of 0.22 Cr..
• For OPM %, as of Mar 2025, the value is -800.00%. The value appears to be declining and may need further review. It has decreased from 0.00% (Sep 2024) to -800.00%, marking a decrease of 800.00%.
• For Other Income, as of Mar 2025, the value is 0.06 Cr.. The value appears to be declining and may need further review. It has decreased from 0.09 Cr. (Sep 2024) to 0.06 Cr., marking a decrease of 0.03 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.15 Cr. (Sep 2024) to 0.12 Cr., marking a decrease of 0.03 Cr..
• For Profit before tax, as of Mar 2025, the value is -0.30 Cr.. The value appears strong and on an upward trend. It has increased from -0.52 Cr. (Sep 2024) to -0.30 Cr., marking an increase of 0.22 Cr..
• For Tax %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00%.
• For Net Profit, as of Mar 2025, the value is -0.30 Cr.. The value appears strong and on an upward trend. It has increased from -0.52 Cr. (Sep 2024) to -0.30 Cr., marking an increase of 0.22 Cr..
• For EPS in Rs, as of Mar 2025, the value is -0.29. The value appears strong and on an upward trend. It has increased from -0.50 (Sep 2024) to -0.29, marking an increase of 0.21.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:02 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Hanman Fit Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -0.78. This value is below the healthy minimum of 5. It has decreased from 0.63 (Mar 24) to -0.78, marking a decrease of 1.41.
• For Diluted EPS (Rs.), as of Mar 25, the value is -0.78. This value is below the healthy minimum of 5. It has decreased from 0.63 (Mar 24) to -0.78, marking a decrease of 1.41.
• For Cash EPS (Rs.), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 3. It has decreased from 0.97 (Mar 24) to -0.52, marking a decrease of 1.49.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.59. It has decreased from 2.37 (Mar 24) to 1.59, marking a decrease of 0.78.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.59. It has decreased from 2.37 (Mar 24) to 1.59, marking a decrease of 0.78.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.02. It has decreased from 0.18 (Mar 24) to 0.02, marking a decrease of 0.16.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 2. It has decreased from -0.04 (Mar 24) to -0.52, marking a decrease of 0.48.
• For PBIT / Share (Rs.), as of Mar 25, the value is -0.78. This value is below the healthy minimum of 0. It has decreased from -0.38 (Mar 24) to -0.78, marking a decrease of 0.40.
• For PBT / Share (Rs.), as of Mar 25, the value is -0.78. This value is below the healthy minimum of 0. It has decreased from 0.18 (Mar 24) to -0.78, marking a decrease of 0.96.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -0.78. This value is below the healthy minimum of 2. It has decreased from 0.63 (Mar 24) to -0.78, marking a decrease of 1.41.
• For PBDIT Margin (%), as of Mar 25, the value is -1,812.78. This value is below the healthy minimum of 10. It has decreased from -22.51 (Mar 24) to -1,812.78, marking a decrease of 1,790.27.
• For PBIT Margin (%), as of Mar 25, the value is -2,690.16. This value is below the healthy minimum of 10. It has decreased from -201.25 (Mar 24) to -2,690.16, marking a decrease of 2,488.91.
• For PBT Margin (%), as of Mar 25, the value is -2,691.14. This value is below the healthy minimum of 10. It has decreased from 97.58 (Mar 24) to -2,691.14, marking a decrease of 2,788.72.
• For Net Profit Margin (%), as of Mar 25, the value is -2,691.14. This value is below the healthy minimum of 5. It has decreased from 335.26 (Mar 24) to -2,691.14, marking a decrease of 3,026.40.
• For Return on Networth / Equity (%), as of Mar 25, the value is -49.12. This value is below the healthy minimum of 15. It has decreased from 26.70 (Mar 24) to -49.12, marking a decrease of 75.82.
• For Return on Capital Employeed (%), as of Mar 25, the value is -49.10. This value is below the healthy minimum of 10. It has decreased from -12.50 (Mar 24) to -49.10, marking a decrease of 36.60.
• For Return On Assets (%), as of Mar 25, the value is -32.44. This value is below the healthy minimum of 5. It has decreased from 19.56 (Mar 24) to -32.44, marking a decrease of 52.00.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.28 (Mar 24) to 0.00, marking a decrease of 0.28.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.28 (Mar 24) to 0.00, marking a decrease of 0.28.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.05 (Mar 24) to 0.01, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1.5. It has decreased from 0.80 (Mar 24) to 0.33, marking a decrease of 0.47.
• For Quick Ratio (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.33, marking a decrease of 0.47.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -1,843.00. This value is below the healthy minimum of 3. It has decreased from -223.50 (Mar 24) to -1,843.00, marking a decrease of 1,619.50.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -2,735.00. This value is below the healthy minimum of 3. It has decreased from 361.50 (Mar 24) to -2,735.00, marking a decrease of 3,096.50.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3.59. It has decreased from 4.98 (Mar 24) to 3.59, marking a decrease of 1.39.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 117.75. This value exceeds the healthy maximum of 3. It has increased from 25.07 (Mar 24) to 117.75, marking an increase of 92.68.
• For EV / EBITDA (X), as of Mar 25, the value is -6.50. This value is below the healthy minimum of 5. It has increased from -111.33 (Mar 24) to -6.50, marking an increase of 104.83.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 126.69. This value exceeds the healthy maximum of 3. It has increased from 22.38 (Mar 24) to 126.69, marking an increase of 104.31.
• For Price / BV (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 1.78 (Mar 24) to 2.31, marking an increase of 0.53.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 126.90. This value exceeds the healthy maximum of 3. It has increased from 22.38 (Mar 24) to 126.90, marking an increase of 104.52.
• For EarningsYield, as of Mar 25, the value is -0.21. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 24) to -0.21, marking a decrease of 0.35.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness